| Name | Title | Contact Details |
|---|
Furiex Pharmaceuticals, Inc., a drug development company, engages in the compound partnering business primarily in the United States. It collaborates with pharmaceutical and biotechnology companies to enhance the value of their drug candidates by applying its novel approach to drug development. The company’s products under development include Eluxadoline1, a mu opioid receptor agonist and delta opioid receptor antagonist, which is in Phase III clinical trials for the treatment of diarrhea-predominant irritable bowel syndrome; and Avarofloxacin1, a Phase III-ready fluoroquinolone antibiotic for the treatment of acute bacterial skin and skin structure infections. It is also developing SYR-472, which is in Phase III clinical trials for the treatment of Type-2 diabetes. In addition, the company has rights to compounds in various stages of development and commercialization, which includes Nesina, Liovel, Oseni, and Kazano for the treatment of Type-2 diabetes, as well as Priligy for the treatment of premature ejaculation. The company was founded in 1998 and is headquartered in Morrisville, North Carolina.
Expression Pathology, Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Gaithersburg, MD. To find more information about Expression Pathology, Inc, please visit www.expressionpathology.com
The Galveston County Health District includes both childhood and adult immunizations in its strategic health plan which is a tool guiding their activities through 2010.
Indianapolis-based GeoH is a Software as a Service (SaaS) company that provides an end-to-end home care software solution. The company was named one of the Top Ten Home Healthcare Solutions Providers in 2020 by Healthcare Tech Outlook. The company was created by agency owners and technologists with more than 20 years of experience working in home health care and technology.
Complementary Healthcare Plans is a Hopkins, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.